Literature DB >> 24172178

Validation of a clinical prediction scale for hospital-onset Clostridium difficile infection.

Subhash Chandra1, Rameet Thapa, Surendra Marur, Niraj Jani.   

Abstract

OBJECTIVE: The aim of this study was to validate a clinical prediction scale for hospital-onset Clostridium difficile infection (CDI).
METHODS: The study included a consecutive cohort of patients admitted to the adult medical service over a period of 17 months (June 2011 to October 2012). The clinical prediction scale comprised of new-onset loose stools (5 points), length of hospital stay >7days (4 points), aged 65 years or older (3 points), resides in long-term care facility (2 points), broad spectrum antibiotics use (1 point), and hypoalbuminemia (1 point). The hospital-onset CDI cases were defined as any new-onset diarrhea after 48 hours of hospital admission that tested positive on polymerase chain reaction assay for C. difficile toxin gene in the absence of history of CDI in the prior 8 weeks. The predictive performance of the scale was assessed using area under the receiver operating curve.
RESULTS: A total of 10,357 patients were admitted to the medical service, of which, 7026 stayed in hospital beyond 48 hours. Mean (SD) age was 68.5 (18.2) years and 41.9% patients were male. A total of 1030 patients were tested for C. difficile toxin gene using polymerase chain reaction assay, of which, 159 patients were positive and 62 of them were unique hospital-onset CDI cases. The scale had area under the receiver operating curve of 0.94 [95% confidence interval (CI), 0.92-0.95]. At the cutoff score of 9, scale was 98.3% (95% CI, 90.2-99.9) sensitive and 85.2% (95% CI, 84.3-86.0) specific.
CONCLUSIONS: Our study results support excellent predictive performance of a clinical prediction scale for hospital-onset CDI. This simple scale can be used in risk stratification leading to prompt tailoring of modifiable risk factors, empirical treatment, and use of probiotics.

Entities:  

Mesh:

Year:  2014        PMID: 24172178     DOI: 10.1097/MCG.0000000000000012

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

1.  Evaluation of the Qiagen artus C. difficile QS-RGQ Kit for Detection of Clostridium difficile Toxins A and B in Clinical Stool Specimens.

Authors:  Nathalie Jazmati; Pia Wiegel; Božica Ličanin; Georg Plum
Journal:  J Clin Microbiol       Date:  2015-03-25       Impact factor: 5.948

2.  Identification of population at risk for future Clostridium difficile infection following hospital discharge to be targeted for vaccine trials.

Authors:  James Baggs; Kimberly Yousey-Hindes; Elizabeth Dodds Ashley; James Meek; Ghinwa Dumyati; Jessica Cohen; Matthew E Wise; L Clifford McDonald; Fernanda C Lessa
Journal:  Vaccine       Date:  2015-10-09       Impact factor: 3.641

3.  Evaluation of a risk score to predict future Clostridium difficile disease using UK primary care and hospital data in Clinical Practice Research Datalink.

Authors:  Clare Marley; Yassine El Hahi; Germano Ferreira; Laura Woods; Ana Ramirez Villaescusa
Journal:  Hum Vaccin Immunother       Date:  2019-04-04       Impact factor: 3.452

4.  A Risk Score to Predict Clostridioides difficile Infection.

Authors:  Laurie Aukes; Bruce Fireman; Edwin Lewis; Julius Timbol; John Hansen; Holly Yu; Bing Cai; Elisa Gonzalez; Jody Lawrence; Nicola P Klein
Journal:  Open Forum Infect Dis       Date:  2021-02-04       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.